Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
about
Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseImaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical ApproachNon-alcoholic fatty liver disease: a practical approach to diagnosis and stagingMagnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysisDiagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysisImaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseNoninvasive Measures of Liver Fibrosis and Severity of Liver Disease.Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis CDiagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data.Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations.Acoustic radiation force impulse elastography, FibroScan®, Forns' index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methodsNon-invasive methods for the diagnosis of nonalcoholic fatty liver diseaseNon-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individualsEffects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.Overview of screening methods for fatty liver disease in children.Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients.Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease.Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.Nonalcoholic fatty liver disease - current status and future directions.Virtual touch quantification (VTq) elastography for non-invasive assessment of liver disease and its complications: what the clinician needs to know.The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Liver Fibrosis: Causes and Methods of Assessment, A Review.JSUM ultrasound elastography practice guidelines: liver.Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.Feasibility of transient elastography versus real-time two-dimensional shear wave elastography in difficult-to-scan patients.Factors Associated with the Quality of Transient Elastography.Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona.Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients.Comparison of Doppler ultrasound and transient elastography in the diagnosis of significant fibrosis in patients with nonalcoholic steatohepatitis.
P2860
Q26764843-AA97F2C0-452F-4672-BCFB-B0993D67BB63Q26771433-8ACEFEE7-1C2C-48A3-8410-56C3DE8FD427Q27006131-494D3350-3B33-43D1-BA7B-06BC6CE54CC4Q30372813-28CC6FA1-457D-45AE-BCB3-7E8908806131Q30374016-04D13874-F396-4822-8FB4-6951C2BCDB95Q30376231-A5C2C0A0-3853-4F9D-89DB-206DE1D2AC26Q30381236-19C157DD-F9EA-486E-B409-446542C0703FQ30386788-04C31A99-BC77-4FC7-AE90-DEDEC626DBDDQ30389544-44BFDA63-FD53-43BA-B9D8-4CFAB04991ACQ30395051-092CA94F-8C48-4C79-8EAB-EFCF39BDA627Q30414130-F10BB1E9-13C0-4A37-9D6D-58DB97E64E77Q30414504-695D274C-8697-423D-A073-E911064F18D3Q30441653-AD57C789-273B-445F-8233-4E98A54987CDQ30453975-8B57C711-F30E-429E-B0FE-2D14283ED99EQ30457472-0CCB5758-0FBE-4AF5-9670-6D58008C8844Q30462755-BA4D76C9-9ABC-4189-B172-93E2C741A7B0Q33639969-2978C8F5-AC66-42A0-8B74-77F9A921A2F8Q35064093-0C98FA8C-3FD9-46B9-A101-A4EF125748E3Q35736511-DB244B3F-4C4A-4802-88BA-511566086A29Q36156172-56775BE2-AB4A-41BA-BF39-77B09A2EFC5AQ36812170-3CAC828E-EA3D-4FA3-AF68-AC91A8270BAAQ37636503-75FE1F66-5B93-44F5-8CD5-325992B22883Q38070696-CDAAFE15-8E16-4793-A2F6-5632C82F104DQ38128548-BBE44816-19AE-4E39-8412-E35031452D6DQ38204970-D239ABA7-604C-4C4E-8272-B90481F9687CQ38212222-60CDEEAE-68A7-402E-B7EA-55E1A83B4CE8Q38494198-618C55FD-C5AB-474B-8D8B-291D184B3980Q38592767-D7997C1A-2136-4A4C-8B42-594546EB733BQ38637486-62A82CA7-30C0-40E3-B289-D40281DD677CQ38656970-6162142B-E397-4FDF-BA36-30D7BC753ACCQ38759277-2BC53B37-9F30-47D9-81DB-151F611FD20AQ38859235-9C765F84-35BD-423C-80A9-575984DF0A3EQ39380465-9AFAFD6C-61F6-4375-A58A-5CB34ED92021Q39678488-F097022D-0262-44D0-913A-0ABA19C0A019Q41440068-D76EED5A-2FB7-4060-899E-D4BB539BDF0AQ42272368-979535A5-1965-4C25-84A6-DC77D4A235C8Q46507190-06BE7BDE-4651-4F72-B48E-013DFCEAC87BQ47561545-A81283DE-ED52-4E29-9B7A-9C8F2C9AD8A2Q47971448-0ACE1888-BD08-428E-9A84-604B46009FFEQ50921407-F01D5847-5905-4C52-9D1D-07D31FF2E267
P2860
Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Discordance in fibrosis stagin ...... using the FibroScan XL probe.
@en
Discordance in fibrosis stagin ...... using the FibroScan XL probe.
@nl
type
label
Discordance in fibrosis stagin ...... using the FibroScan XL probe.
@en
Discordance in fibrosis stagin ...... using the FibroScan XL probe.
@nl
prefLabel
Discordance in fibrosis stagin ...... using the FibroScan XL probe.
@en
Discordance in fibrosis stagin ...... using the FibroScan XL probe.
@nl
P2093
P1476
Discordance in fibrosis stagin ...... using the FibroScan XL probe.
@en
P2093
Andres Duarte-Rojo
David Wong
Gilles Pomier-Layrargues
Magdy Elkashab
Mark Levstik
Melanie Beaton
Pam Crotty
Richard Kirsch
Robert P Myers
P304
P356
10.1016/J.JHEP.2011.10.007
P577
2011-10-23T00:00:00Z